沙坦类降压药因其降压作用显著 ,尤其对心血管疾病的独特疗效和保护作用 ,已引起临床普遍关注 ,且长期应用无干咳、停药反跳及体位性低血压等不良反应 ,已由 WHO列为一线降压药。本文简述沙坦类降压药临床研究现状。 Because of its antihypertensive effect, sartan antihypertensive drugs are of particular interest in cardiovascular diseases and their protective effects have drawn widespread clinical attention. Long-term applications include no adverse reactions such as dry cough, withdrawal rebound and postural hypotension, Has been listed by the WHO as a first-line antihypertensive drug. This article describes the status of clinical studies of sartan antihypertensive drugs.